The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis

The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis

Status unknownNot a drug-phase studyMS (type not specified)NCT04787497

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • High Phenolic Extra Virgin Olive Oil

What it measured

Main measures

  • Symbol Digits Modalities Test (SDMT)

    baseline, 6-months, 12-months

    Thinking and memory

  • California Verbal Learning Test-Second Edition (CVLT-II)

    baseline, 6-months, 12-months

  • Brief Visuospatial Memory Test-Revised (BVMT-R)

    baseline, 6-months, 12-months

    Thinking and memory

  • Wisconsin Card Sorting Test (WCST)

    baseline, 6-months, 12-months

    Thinking and memory

  • Trail Making Test (TMT)

    baseline, 6-months, 12-months

    Thinking and memory

  • The Vocabulary and Block Design from the Wechsler Adult Intelligence Scale (WAIS)

    baseline

  • The Digit Span Test (DST) from WAIS

    baseline, 6-months, 12-months

    Thinking and memory

  • Word List Generation (WLG) Test

    baseline, 6-months, 12-months

  • Faux Pas Recognition (FPR) Test

    baseline, 6-months, 12-months

    Thinking and memory

  • Hospital Anxiety and Depression Scale (HADS)

    baseline, 6-months, 12-months

    Mood and sleep

  • Health Status Questionnaire (SF-36)

    baseline, 6-months, 12-months

    Quality of life (reported by participants)

  • Modified Fatigue Impact Scale (MFIS)

    baseline, 6-months, 12-months

    Fatigue

Who could take part

MS (type not specified) · 18 to 65

Show the full criteria

Inclusion criteria

* Clinical diagnosis of MS * Must be between 18 to 65 years of age * Both males and females are eligible for participation * Must have at least five years of education * Must be fluent in Greek language

Exclusion criteria

* Other neurological, psychiatric or chronic condition * Enrollment in other trials/drug studies * Experiencing side effects from previous treatments * Inadequate visual and auditory acuity

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This is an open label feasibility trial to examine the effect of a complementary treatment with High Phenolic Extra Virgin Olive Oil (HPEVOO) on the cognitive and mental health of people with Multiple Sclerosis (MS), while receiving their standard medical treatment.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        May 2022

      2. Main results due

        May 2024

      3. Finished

        Sept 2024

      Assembled by software from public sources.